| Authors: |
Ewbank J; European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), Brussels, Belgium. jonathan.ewbank@erinha.eu.; Institut National de la Santé et de la Recherche Médicale, Paris, France. jonathan.ewbank@erinha.eu., Pályi B; National Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary., Szekely Björndal Å; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden., David R; European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), Brussels, Belgium., Pete J; Unit of Export Control, Department of Trade, Defense Industry, Export Control and Precious Metal Assay, Government Office of the Capital City Budapest, Budapest, Hungary., Zatloukal K; Diagnostic and Research Institute of Pathology, Diagnostic & Research Center of Molecular Biomedicine, Medical University of Graz, Graz, Austria. |
